PULMATRIX, INC. Operating Leases, Rent Expense
PULMATRIX, INC. (PULM) reported Operating Leases, Rent Expense of $20.00 thousand for the 12-month period ending 2015-03-31, per its 10-K filed 2015-06-10.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseAndRentalExpense · last filed 2015-06-10
- PULMATRIX, INC. operating leases, rent expense for fiscal 2015 was $20.00K, a 0.00% change from fiscal 2014.
- PULMATRIX, INC. operating leases, rent expense for fiscal 2014 was $20.00K.
| Period end | Operating Leases, Rent Expense 0 month | Operating Leases, Rent Expense 12 month |
|---|---|---|
| 2015-03-31 | $20.00K 10-K · filed 2015-06-10 | |
| 2015-02-11 | $1.70K 10-K · filed 2015-06-10 | |
| 2014-03-31 | $20.00K 10-K · filed 2015-06-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |